Introduction {#s1}
============

Deliberate self-harm (DSH) is a health risk behavior defined as an act of intentional bodily harm without apparent suicidal intent ([@B1]). DSH is one of the most common self-destructive behaviors in patients with substance use disorders such as alcohol dependence, cannabis abuse, and other illicit drug use ([@B2]--[@B5]). In addition to injuries, infections, and tissue damage resulted from DSH, studies have demonstrated that DSH is significantly associated with a variety of psychosocial problems such as depression, anxiety, and loneliness, functional impairment, poor quality of life, premature death, later attempted suicide, and subsequent suicide ([@B6]--[@B10]). Further, DSH also has major negative impacts on the self-harmer\'s loved ones, including psychological distress, feelings of guilt, social isolation, and stigma ([@B11]). Therefore, the identification and treatment of DSH is an essential component of clinical management of patients with drug use disorders.

Worldwide, opioids are the most harmful drug, representing 70% of the burden of disease attributable to drug use disorders ([@B12]), and heroin is the second most common drug of abuse in China ([@B13]). Therefore, clinical management of heroin (and other opioids) dependence is one of the highest priorities of psychiatric services for many countries in the world, including China. In contemporary China, compulsory detoxification is the main type of treatment for illicit drug dependence, managed by departments of public security of the government. This is supplemented by voluntary detoxification services, provided by psychiatric specialty hospitals ([@B14]). In 2016, a total of 661,000 newly-registered illegal drug users were receiving treatment in mainland China: 91.1% compulsory and 8.9% voluntary ([@B15]). However, due to healthcare providers\' limited knowledge and skills in managing self-harm, DSH might be an underecognized and undertreated issue in drug dependence treatment settings ([@B14], [@B16], [@B17]); this situation is particularly serious in China\'s compulsory detoxification settings because of a shortage of medical professionals in these institutions ([@B14]).

DSH is also prevalent in the general population, in particular younger age-groups, and it manifests in various forms, with cutting accounting for approximately 70% of the individuals who harm themselves ([@B18], [@B19]). Because heroin acts upon the central nervous system and results in alterations in the users\' perception, mood, consciousness, attention or behavior, rates and methods of DSH of heroin-dependent patients (HDPs) might be different from those of the general population. Nevertheless, in international literature, there is a dearth of studies examining DSH in HDPs. To the best of our knowledge, only one study reported a lifetime DSH prevalence of 25% in a sample of opioid-dependent patients in Australia but the clinical characteristics of self-harmers such as DSH methods have not been fully elucidated ([@B20]). By contrast, there have been some studies on the DSH of HDPs in China ([@B21]--[@B35]). However, most of these available studies were published in Chinese-language journals, and are therefore less accessible to the international readership.

DSH patients with heroin dependence present a considerable challenge for clinical services. A greater understanding on the prevalence and methods of DSH would help address this important clinical problem. Existing Chinese studies have reported a wide variations in the prevalence of DSH among HDPs (1.1--17.7%) and presented a mixed profile of DSH methods ([@B21], [@B26], [@B32]). To help clarify these issues, this meta-analysis quantitatively synthesized the results of relevant studies to determine the prevalence rates of DSH and its methods of Chinese HDPs.

Materials and methods {#s2}
=====================

This meta-analysis is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-analysis of Observational Studies in Epidemiology guidelines.

Search strategy
---------------

We searched potential articles with search engines including PubMed, Embase, PsycInfo, China National Knowledge Infrastructure, Wanfang, and SinoMed. To avoid omission of relevant studies, we also hand-searched the reference lists of all identified relevant papers and reviews. Keywords used for the literature search included (heroin OR opiate OR opioids OR abstinence OR narcotic OR detoxification) AND (self-harm OR self-injuri^\*^ OR self-mutilation OR parasuicide OR self-destruct^\*^ OR self-inflict^\*^ OR self-wound^\*^). All papers published by March 20, 2018 were included.

Selection criteria
------------------

Inclusion criteria were (1) cross-sectional studies with meta-analyzable data (i.e., reporting the DSH prevalence or number of patients with DSH and sample size); (2) study subjects were Chinese HDPs, regardless of other illicit drugs of abuse (as long as heroin was the main drug of abuse); and (3) the presence of DSH could be determined by any approaches (i.e., clinical interview, self-report questionnaire) but the act of self-harm should be done without suicidal intent.

Data extraction
---------------

The following information were independently extracted from each included study: first author, publication year, study period, sample characteristics (percentage of males and mean age), diagnostic criteria of heroin dependence, type of treatment, assessment of DSH, sampling method, response rate, sample size, number of DSH patients, and numbers of patients with different subtypes of DSH.

Quality assessment
------------------

The validity of prevalence studies that involve psychiatric patients is mainly determined by the sample representativeness and the accuracy of outcome assessment ([@B14], [@B36], [@B37]). In this study, the former depends on sample size, sampling method, and response rate, and the latter is determined by the validity of the assessment ([@B14], [@B37]). In the case of our study, studies having a minimum number of 100 HDPs, recruiting subjects by using cluster sampling, having a response rate of 70% and above, and assessing DSH in a reliable way (i.e., with validated standardized scales such as NSSI-AT \[Non-Suicidal Self-Injury-Assessment Tool\] and clinical interview) were regarded as having high quality, whereas studies having a sample of 99 HDPs or fewer, recruiting subjects by using convenient sampling, having a response rate of less than 70% or assessing DSH in a questionable way (i.e., with unvalidated or unstandardized scales) were regarded as having poor quality ([@B14]).

Two authors (YMX and WCC) independently searched literature databases, evaluated the eligibility of potential studies, extracted data, and assessed quality of included studies. Any discrepancies were resolved by consensus of the two authors after reviewing the primary data again.

Statistical analysis
--------------------

We used meta-analysis to produce combined estimates and their 95% confidence intervals (CIs) for the prevalence rates of DSH and its methods in the whole sample. Forest plots were used to show the prevalence rates and the combined estimates. When there was evidence of heterogeneity (*I*^2^ \> 50%), prevalence rates were combined by using a random-effect model; otherwise, rates were combined by using the fixed-effect model. Sources of heterogeneity in the prevalence estimates of DSH were explored by subgroup analyses according to sample characteristics (reported vs. not reported), diagnostic criteria for heroin dependence (reported vs. not reported), middle year of the observation period (\<2,000 vs. ≥2,000), type of detoxification (compulsory vs. voluntary), study quality (high vs. low), and sample size (≤1,255 vs. \>1,255). Significance of differences in DSH prevalence estimates between subgroups was tested with Q-value test. We used funnel plot and Begg\'s/Egger\'s tests to test publication bias. Rates were transformed using the Freeman-Turkey variant of the arcsine square root transformation before pooling. All analyses were performed using R 3.1.1 (R Development Core Team; Vienna, Austria).

Results {#s3}
=======

Our literature search identified 132 unique candidate articles, of which 117 were excluded due to different reasons (Figure [1](#F1){ref-type="fig"}). Finally, 15 studies with a total of 37,243 Chinese HDPs were included in this meta-analysis ([@B21]--[@B35]). All included studies were published in Chinese. HDPs of 14 studies were receiving compulsory detoxification treatment and patients of the remaining one were receiving voluntary detoxification treatment ([@B31]). Therefore, subjects of this meta-analysis were limited to HDPs of detoxification institutions. In total, these included studies reported over ten methods of DSH. Characteristics of the included studies were displayed in Table [1](#T1){ref-type="table"}.

![Flowchart of study inclusion.](fpsyt-09-00325-g0001){#F1}

###### 

Basic characteristics, quality, and numbers of DSH patients by methods of included studies.

  **Study**                **Sample characteristics (% men, % of age-group or mean age)**   **Diagnostic criteria for heroin dependence**   **Observation period**   **Type of treatment**   **DSH assessment**   **Sampling**   **Response rate (%)**   **Quality**   **No. of self-harmers**   **No. of HDPs**   **No. of HDPs by DSH methods**
  ------------------------ ---------------------------------------------------------------- ----------------------------------------------- ------------------------ ----------------------- -------------------- -------------- ----------------------- ------------- ------------------------- ----------------- ----------------------------------------
  Shen, et al. ([@B22])    NR                                                               DSM-III-R                                       1990--96                 C                       MR                   C              100                     Low           200                       14,000            S:132, C:25, B:24, J:14, D:3, O:2
  Zhu, et al. ([@B23])     75.3% men, 30.3 years                                            NR                                              1996--98                 C                       MR                   C              100                     Low           32                        591               S:21, C:9, H:2
  Luo, et al. ([@B24])     74.3% men, 90.3% \<35 years                                      NR                                              1994--98                 C                       MR                   C              100                     Low           51                        1,255             S:37, C:12, H:2
  Feng, et al. ([@B35])    NR                                                               NR                                              2001--02                 C                       MR                   C              100                     Low           80                        4,523             S:66, C:9, B:1, H:2, O:2
  Wang, ([@B26])           NR                                                               NR                                              1998--99                 C                       CI & PE              C              100                     High          58                        327               S:45, C:10, H:3
  Liu, ([@B27])            NR                                                               NR                                              1999--2000               C                       MR                   C              100                     Low           95                        883               S:21, C:8, B:55, H:10, Cu:1
  Yang, ([@B28])           NR                                                               NR                                              1998--2003               C                       MR                   C              100                     Low           8                         627               NR
  Xia, et al. ([@B21])     NR                                                               CCMD-3                                          2001--02                 C                       MR                   C              100                     Low           20                        1,760             NR
  Jia, ([@B29])            NR                                                               NR                                              1996--2002               C                       MR                   C              100                     Low           42                        527               S:42
  Lu, et al. ([@B30])      NR                                                               NR                                              1997--2002               C                       MR                   C              100                     Low           102                       2,108             S:35, C:65, Br:1, K:1
  Tao, et al. ([@B31])     NR                                                               DSM-IV                                          2002--03                 V                       MR                   C              100                     Low           8                         196               NR
  Zhang, et al. ([@B32])   85.3% men, 31 years                                              DSM-III-R                                       1997--2001               C                       CI & PE              C              100                     High          315                       3,258             S:185, C:96, B:13, Cu:2, J:4, A:8, O:7
  Wang, ([@B33])           NR                                                               NR                                              2001--03                 C                       MR                   C              100                     Low           52                        2,827             S:44, C:4, A:1, O:3
  Wu, et al. ([@B34])      NR                                                               DSM-IV                                          2002--06                 C                       MR                   C              100                     Low           79                        3,841             S:61, O:18
  Luo, ([@B35])            NR                                                               DSM-IV-R                                        2008--09                 C                       MR                   C              100                     Low           20                        520               S:6, H:14

*DSH, deliberate self-harm; NR, not reported; HDPs, heroin-dependent patients*.

*Sample characteristics: percentage of males and mean age (or percentage of an age-group)*.

*Diagnostic criteria for heroin dependence: DSM, Diagnostic and Statistical Manual of Mental Disorders; CCMD, Chinese Classification and Diagnostic Criteria of Mental Disorders*.

*Type of treatment: C, compulsory detoxification; V, voluntary detoxification*.

*DSH assessment: MR, medical records; CI and PE, clinical interview and physical examination*.

*Sampling: C, cluster sampling*.

*DSH methods of self-harm: S, swallowing foreign objects such as broken glass, iron nails, keys, lighter, paperclip, scissors, belt fastener, and nail clipper; C, cutting oneself with broken glasses, chopsticks, ring-pull can, and so on; B, burning oneself with cigarette, hot water, and so on; H, hitting oneself with a hard object and hands, or hitting heavy objects (such as a wall); Cu, cutting off fingers; J, jumping from height; Br, breaking bones; K, knocking a nail into the head; A, apastia; D, drug overdose; O, others*.

Two studies assessed the presence of DSH by using a combined approach of clinical interview and physical examination ([@B26], [@B32]), and the rest assessed DSH based on a retrospective review of medical records. Although DSH cases ascertained by the two approaches excluded self-harmers with suicidal intent, we considered that the later assessment was questionable, because it is very likely that only moderate-to-severe DSH cases that need medical treatment could be identified in the medical records. All studies chose subjects by using cluster sampling (i.e., non-selectively included all HDPs of an institution during the observation period), and therefore the response rates were all 100%. Sample sizes of included studies ranged between 196 and 14,000, with a median value of 1,255. As a results of these reasons, only two studies were rated "high" for the overall quality rating, and the remaining 13 studies were rated "low" (Table [1](#T1){ref-type="table"}).

A high level of heterogeneity was found in the prevalence of DSH across all included studies (*I*^2^ = 98%, *P* \< 0.001). The pooled prevalence (95%CI) of DSH from the random-effect model among Chinese HDPs was 4.4% (2.8, 6.2%) (Figure [2](#F2){ref-type="fig"}). The combined rates of DSH methods of Chinese HDPs (in order of prevalence) were 2.7% (95%CI: 1.6, 4.4%) for swallowing foreign objects, 0.9% (95%CI: 0.4, 1.9%) for cutting, 0.5% (95%CI: 0.2, 1.5%) for hitting, 0.4% (95%CI: 0.01, 3.3%) for burning, 0.1% (95%CI: 0.03, 0.2%) for jumping from height, 0.1% (95%CI: 0.01, 0.2%) for cutting off fingers, 0.1% (95%CI: 0.01, 0.7%) for apastia, 0.05% (95%CI: 0.001, 0.3%) for breaking bones, 0.05% (95%CI: 0.001, 0.3%) for knocking a nail into the head, and 0.02% (95%CI: 0.001, 0.1%) for drug overdose.

![Forest plot of prevalence of deliberate self-harm among Chinese patients with heroin dependence.](fpsyt-09-00325-g0002){#F2}

Although the shape of the funnel plot seems asymmetrical (Figure [3](#F3){ref-type="fig"}), results of Egger\'s test (*t* = 0.529, *P* = 0.606) and Begg\'s test (*Z* = 0.148, *P* = 0.882) showed that there was no significant publication bias in all included studies.

![Funnel plot of publication bias among the 15 included studies.](fpsyt-09-00325-g0003){#F3}

Results of subgroup analyses are displayed in Table [2](#T2){ref-type="table"}. The prevalence of DSH was significantly higher in studies conducted before 2000 (vs. those conducted after 2000) and in studies rated as high quality (vs. those rated as low quality).

###### 

Subgroup analysis of the source of heterogeneity of included studies.

  **Factor**                                      **No. of studies**   **No. of DSH cases**   **No. of HDPs**   **Heterogeneity (*I*^2^, *P*)**   **Pooled rate (%, 95%CI)**   **Q**    **P**
  ----------------------------------------------- -------------------- ---------------------- ----------------- --------------------------------- ---------------------------- -------- ---------
  **SAMPLE CHARACTERISTICS**                                                                                                                                                            
  Not reported                                    12                   764                    32,139            97%, *P* \< 0.001                 3.9 (2.6, 5.5)                        
  Reported                                        3                    398                    5,104             96%, *P* \< 0.001                 6.2 (3.0, 10.6)              1.995    0.158
  **DIAGNOSTIC CRITERIA FOR HEROIN DEPENDENCE**                                                                                                                                         
  Not reported                                    9                    520                    13,668            97%, *P* \< 0.001                 5.2 (3.1, 7.9)                        
  Reported                                        6                    642                    23,575            99%, *P* \< 0.001                 3.2 (1.2, 6.2)               0.775    0.379
  **MIDDLE YEAR OF THE OBSERVATION PERIOD**                                                                                                                                             
  \<2000                                          8                    895                    22,949            99%, *P* \< 0.001                 7.0 (3.6, 11.4)                       
  ≥2000                                           7                    267                    14,294            70%, *P* \< 0.001                 1.9 (1.4, 2.4)               10.309   0.001
  **TYPE OF DETOXIFICATION**                                                                                                                                                            
  Compulsory                                      14                   1,154                  37,047            98%, *P* \< 0.001                 4.4 (2.8, 6.3)                        
  Voluntary                                       1                    8                      196               --                                4.1 (1.7, 7.4)               0.032    0.858
  **SAMPLE SIZE**                                                                                                                                                                       
  ≤1,255                                          8                    314                    4,926             95%, *P* \< 0.001                 6.2 (3.5, 9.5)                        
  \>1,255                                         7                    848                    32,317            99%, *P* \< 0.001                 2.8 (1.3, 4.8)               3.551    0.06
  **STUDY QUALITY**                                                                                                                                                                     
  High                                            2                    373                    3,585             94%, *P* \< 0.001                 13.2 (6.4, 22.1)                      
  Low                                             13                   789                    33,658            96%, *P* \< 0.001                 3.4 (2.3, 4.6)               13.757   \<0.001

Discussion {#s4}
==========

This meta-analysis summarized studies reporting the prevalence rates of DSH and its methods among Chinese HDPs receiving detoxification treatment. We found that 4.4% Chinese HDPs had comorbid DSH and that the most common DSH method was swallowing foreign objects (2.7%), accounting for 61.4% of the self-harmers. Further, some other extreme forms of DSH such as jumping from height (0.1%), cutting off fingers (0.1%), and breaking bones (0.05%) were also not uncommon in Chinese HDPs.

In the literature, DSH prevalence rates in adolescents (7.5--46.5%) and adults (4--23%) vary considerably ([@B38]). Many factors may contribute to variation in DSH rates, including differences in definition (i.e., self-harming behavior vs. non-suicidal self-injury disorder), assessment (i.e., clinical interview vs. self-report questionnaire), and timeframe of interest (i.e., lifetime vs. twelve-month), and developmental context. With regard to DSH among international patients with substance use disorders, a 1-week prevalence of 6.9% and a lifetime prevalence of 25.0--45.5% have been reported ([@B20], [@B39]--[@B41]). It seems that the risk of DSH in Chinese HDPs receiving detoxification treatment is lower than that in the general population and international patients with substance use disorders. However, this may not be true because the current study focused on the prevalence of DSH during the period of detoxification treatment only, not DSH in the past week/year or during the lifetime. The other explanation for the relatively low pooled prevalence of DSH found in this meta-analysis is the problematic assessment of DSH used in most of the included studies---based on medical records only, an approach would miss quite a lot of cases with minor DSH that requires no medical attention. This speculation is supported by the results of subgroup analysis based on study quality: the pooled DSH prevalence of studies based on clinical interview and physical examination is nearly 4-fold higher than that of studies based on medical records (13.2 vs. 3.4%). In addition, one of our included studies compared the prevalence of DSH between HDPs under compulsory detoxification and prisoners of theft and found a significantly higher risk of DSH in HDPs than prisoners (1.28 vs. 0.27%) ([@B28]). Due to these reasons, the true prevalence of DSH in Chinese HDPs receiving treatment should be higher than what we observed in this study, at least 13.2%.

DSH generally occurs when someone intentionally herself/himself in a way that is not intended to be lethal. In adolescents and adult population, the most frequent method of DSH is self-cutting, followed by head banging scratching, hitting, and burning ([@B38]). In a mixed sample of patients with substance (cannabis, heroin, phensedyl, alcohol, and other drugs) use disorders, the two most common types of DSH were cutting and burning, representing 39.0 and 26.0% of the self-harmers, respectively ([@B41]). On the contrary, the meta-analysis found a different pattern of DSH methods in Chinese HDPs: swallowing foreign objects is the most common, and some other more lethal forms of DSH such as jumping from a high place and knocking a nail into the head occur too. A prognostic analysis of 48 Chinese HDPs who intentionally swallowed sharp foreign objects reported that 38 (79.2%) patients received surgical treatment and one patient (2.1%) died due to hemorrhagic shock ([@B42]). Therefore, our data suggest that the self-harmers of Chinese HDPs have a higher likelihood of harming themselves in a dangerous or life-threatening way.

Until now, empirical studies have provided evidence for some functions of DSH, including affect-regulation and self-punishment ([@B43], [@B44]). Because DSH is a way to quickly relieve overwhelming negative feelings, the severe painful feelings and depressive and anxiety symptoms of the HDPs may be the primary reason for DSH during the acute withdrawal period. On the other side, HDPs may feel guilt for their past misconduct behaviors and punish themselves for being addicts. Intolerable withdrawal symptoms, feelings of guilt and emptiness, public stigma toward persons with drug addiction, being abandoned by family members, and even death wish may together result in the more lethal DSH methods of HDPs. In China, compulsory detoxification treatment is also an administrative punishment for HDPs who refused voluntary detoxification or relapse on heroin. Therefore, HDPs may also use self-harm, in particular more fatal methods of self-harm, as a means to escape punishment, i.e., getting the chance of being released on bail for medical services ([@B24]).

Subgroup analyses found that in addition to difference by study quality, the study\'s observation period was also associated with the pooled prevalence of DSH among Chinese HDPs. The low DSH prevalence in 2000 and onwards relative to before 2000 might be a result of the improvement in the clinical management of heroin dependence in recent years.

Our study has several limitations. First, 13 of the 15 included studies were of low quality, and our subgroup analysis found significantly lower DSH prevalence in low quality studies. Thus, as we discussed above, this meta-analysis under-estimates the true prevalence. Second, there was significant heterogeneity in the estimated DSH prevalence across studies, even after the subgroup analyses according to some potential sources of heterogeneity. Third, due to incomplete reporting of the results of included studies, the gender difference in DSH prevalence could not be examined in this study. Finally, subjects of all included studies were those receiving detoxification treatment at institutions. We did not identify any studies on DSH of untreated patients, patients of methadone maintenance treatment clinics, or remitted patients. We need to be cautious in generalizing findings of the present study due to the limited sample representativeness of Chinese HDPs.

Patient safety is the cornerstone of detoxification treatment for institutionalized HDPs. Health care workers must provide a safe environment for HDPs in China\'s detoxification institutions. Precautionary measures may include evaluation of the care setting prior to admitting the patient, removal of any items that patients could use to harm themselves, periodical examination of admitted patients\' belongings and removing any prohibited items, and reducing patients\' chances of accessing prohibited items.

Because of the methodology problems in the available studies, we found a relatively low prevalence of DSH among Chinese HDPs receiving detoxification treatment. Nevertheless, we found that the self-harmers of Chinese HDPs were more likely to harm themselves by using more lethal methods. Given the many negative consequences of DSH and its prevalent methods identified in this meta-analysis, screening for those at risk for DSH and other self-destructive behaviors, strengthening the management of potentially dangerous goods, and maintaining a safe environment should be prioritized for the clinical management of HDPs in China\'s detoxification treatment settings. Importantly, restricting the availability of DSH methods may be an effective way to prevent or reduce DSH.
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